Hyaluronan, CD44 and Emmprin: Partners in cancer cell chemoresistance
Author:
Publisher
Elsevier BV
Subject
Pharmacology (medical),Infectious Diseases,Cancer Research,Pharmacology,Oncology
Reference156 articles.
1. Intronic splicing of hyaluronan synthase 1 (HAS1): a biologically relevant indicator of poor outcome in multiple myeloma;Adamia;Blood,2005
2. Soluble CD44 inhibits melanoma tumor growth by blocking cell surface CD44 binding to hyaluronic acid;Ahrens;Oncogene,2001
3. Cancer stem cells in solid tumors;Ailles;Curr. Opin. Biotechnol.,2007
4. Prospective identification of tumorigenic breast cancer cells;Al-Hajj;Proc. Natl. Acad. Sci. U.S.A.,2003
5. Human mesothelioma cells produce factors that stimulate the production of hyaluronan by mesothelial cells and fibroblasts;Asplund;Cancer Res.,1993
Cited by 154 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Umbrella Review on Cancer Stem Cell in Oral and Head and Neck Squamous Cell Carcinoma;Journal of Stem Cells and Regenerative Medicine;2024-12-31
2. Therapeutic implications of signaling pathways and tumor microenvironment interactions in esophageal cancer;Biomedicine & Pharmacotherapy;2024-07
3. Dissecting gastric cancer heterogeneity and exploring therapeutic strategies using bulk and single-cell transcriptomic analysis and experimental validation of tumor microenvironment and metabolic interplay;Frontiers in Pharmacology;2024-06-19
4. The potential mechanism of HIF-1α and CD147 in the development of triple-negative breast cancer;Medicine;2024-06-07
5. A Single-Center Retrospective Analysis of Kaposi's Sarcoma: Is There a Relationship Between Emmprin/CD147 Expression and Biological Behavior?;International Journal of Surgical Pathology;2024-01-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3